Delivery Order SPE2DB24D2003-SPE2DB25FXFJ4
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$6.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the purchase of 4,567,175,269 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $12,156.98 firm fixed-price delivery order has a completion date of February 6, 2025 and is not designated under any set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,477.96 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 8, 2024 with a completion date of July 9, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $16,436.31 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024 with a completion date of December 10, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award is for the delivery of 4,566,601,644 units of the pharmaceutical product Ondansetron ODT 4 mg tablets in 30-count packages. The award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 3, 2024. The contract has a ceiling value of $1,293.48 and a completion date of December 4, 2024. It is a firm fixed-price delivery order contract with no set-aside requirements....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,517.76 firm fixed-price delivery order is for the supply of 4,567,331,384 units of ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of February 21, 2025 and does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $12,751.76 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of 4,564,990,448 units of ondansetron ODT 4 mg tablets to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing...
This federal contract award is for the delivery of 4,565,255,906 units of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The $15,177.45 contract is a Firm Fixed Price Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $5,612.18 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,401,649 units of ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of 4,565,471,054 units of ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $25,066.79, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of August 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of 4563816196 Ondansetron ODT 4 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA). The $16,342.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The ultimate completion date for this order is March 1, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...